Protalix BioTherapeutics Inc (FRA:PBDA)
€ 1.043 -0.0215 (-2.02%) Market Cap: 79.07 Mil Enterprise Value: 62.01 Mil PE Ratio: 58.00 PB Ratio: 2.52 GF Score: 54/100

Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts

  • 1